Reported 3 days ago
OrthoPediatrics Corp. (KIDS) has been highlighted by Conestoga Capital Advisors for its impressive momentum in the pediatric orthopedic market, despite recent stock declines. In Q1 2025, the company reported better-than-expected results, achieving revenue growth of 40% from the previous year, with positive EBITDA and strong profitability plans. While its stock has faced challenges, KIDS remains a notable player in children's orthopedic care.
Source: YAHOO